Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

FFA and FAPD might be related or stages of the same disease.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Some women with common hair loss may develop permanent hair loss.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Traction may not be the only cause of cicatricial marginal alopecia.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Two mouse mutations cause similar hair loss despite different skin changes.

Hydroxychloroquine can help treat certain types of hair loss.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

There is no standard treatment for CCCA, and practices vary widely.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Black women with CCCA are more likely to have uterine fibroids.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Early diagnosis and treatment of favus can prevent permanent hair loss.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Adding nano fat to hair transplants improves results for scar-related hair loss.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.